Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members

[1]  S. Cialfi,et al.  Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members , 2014, BMC Cancer.

[2]  R. Kappler,et al.  Identification of BMP2 as an epigenetically silenced growth inhibitor in rhabdomyosarcoma. , 2014, International journal of oncology.

[3]  S. Wang,et al.  TGF-β1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma , 2014, Oncogene.

[4]  Yang Yang,et al.  Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer. , 2014, European journal of cancer.

[5]  Steven Y. Cheng,et al.  MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis , 2014, Oncotarget.

[6]  G. Wang,et al.  miR-203, a Tumor Suppressor Frequently Down-regulated by Promoter Hypermethylation in Rhabdomyosarcoma* , 2013, The Journal of Biological Chemistry.

[7]  O. Slabý,et al.  MicroRNAs involved in skeletal muscle development and their roles in rhabdomyosarcoma pathogenesis , 2013, Pediatric blood & cancer.

[8]  Chen-Yu Zhang,et al.  Potential microRNA targets for cancer chemotherapy. , 2013, Current medicinal chemistry.

[9]  E. Choy,et al.  Role of Epigenetic Modulation for the Treatment of Sarcoma , 2013, Current Treatment Options in Oncology.

[10]  M. Fabbri.  MicroRNAs and cancer: towards a personalized medicine. , 2013, Current molecular medicine.

[11]  A. Rishi,et al.  Upregulation of miR-150* and miR-630 Induces Apoptosis in Pancreatic Cancer Cells by Targeting IGF-1R , 2013, PloS one.

[12]  L. Zentilin,et al.  MiR-378 Controls Cardiac Hypertrophy by Combined Repression of Mitogen-Activated Protein Kinase Pathway Factors , 2013, Circulation.

[13]  Yanan Guo,et al.  MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer. , 2013, Gene.

[14]  P. Picci,et al.  miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control. , 2013, International Journal of Oncology.

[15]  Honglin Liu,et al.  Discovery of MicroRNAs Associated with Myogenesis by Deep Sequencing of Serial Developmental Skeletal Muscles in Pigs , 2012, PloS one.

[16]  M. Bonin,et al.  Differential expression of miRNAs in rhabdomyosarcoma and malignant rhabdoid tumor. , 2012, Experimental cell research.

[17]  Chad E. Grueter,et al.  Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378* , 2012, Proceedings of the National Academy of Sciences.

[18]  Jin-feng Zhang,et al.  MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis , 2012, Medical Oncology.

[19]  I. Knezevic,et al.  A Novel Cardiomyocyte-enriched MicroRNA, miR-378, Targets Insulin-like Growth Factor 1 Receptor , 2012, The Journal of Biological Chemistry.

[20]  Subbaya Subramanian,et al.  Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma , 2012, Laboratory Investigation.

[21]  X. Gu,et al.  microRNA expression profiles in human colorectal cancers with brain metastases. , 2012, Oncology letters.

[22]  Hui Zhou,et al.  Insulin-Like Growth Factor-1 Receptor Is Regulated by microRNA-133 during Skeletal Myogenesis , 2011, PloS one.

[23]  Norbert Gretz,et al.  miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.

[24]  Xiang-Sun Zhang,et al.  NOA: a novel Network Ontology Analysis method , 2011, Nucleic acids research.

[25]  Ryan M. Layer,et al.  MicroRNA-378 Targets the Myogenic Repressor MyoR during Myoblast Differentiation* , 2011, The Journal of Biological Chemistry.

[26]  A. Martins,et al.  Targeting the Insulin-Like Growth Factor Pathway in Rhabdomyosarcomas: Rationale and Future Perspectives , 2011, Sarcoma.

[27]  Nicholas Bertos,et al.  miR-378(∗) mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway. , 2010, Cell metabolism.

[28]  A. Palmieri,et al.  MicroRNA Expression Profiling of Oral Carcinoma Identifies New Markers of Tumor Progression , 2010, International journal of immunopathology and pharmacology.

[29]  H. Lodish,et al.  Distinct roles for miR‐1 and miR‐133a in the proliferation and differentiation of rhabdomyosarcoma cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  D. Machin,et al.  Outcomes in paediatric metastatic rhabdomyosarcoma: results of The International Society of Paediatric Oncology (SIOP) study MMT-98. , 2010, European journal of cancer.

[31]  O. Delattre,et al.  MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas , 2010, British Journal of Cancer.

[32]  L. Stein,et al.  A human functional protein interaction network and its application to cancer data analysis , 2010, Genome Biology.

[33]  M. Robinson,et al.  A scaling normalization method for differential expression analysis of RNA-seq data , 2010, Genome Biology.

[34]  Ji Wan,et al.  Structure and activity of putative intronic miRNA promoters. , 2010, RNA.

[35]  H. Dombret,et al.  Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  D. Catalucci,et al.  Reciprocal Regulation of MicroRNA-1 and Insulin-Like Growth Factor-1 Signal Transduction Cascade in Cardiac and Skeletal Muscle in Physiological and Pathological Conditions , 2009, Circulation.

[37]  S. Durinck,et al.  microRNA Profiling Identifies Cancer-Specific and Prognostic Signatures in Pediatric Malignancies , 2009, Clinical Cancer Research.

[38]  M. Ladanyi,et al.  The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. , 2009, The Journal of clinical investigation.

[39]  R. Gregory,et al.  Many roads to maturity: microRNA biogenesis pathways and their regulation , 2009, Nature Cell Biology.

[40]  M. Bernstein,et al.  Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells , 2008, Cancer Cell International.

[41]  T O Nielsen,et al.  MicroRNA expression signature of human sarcomas , 2008, Oncogene.

[42]  Stijn van Dongen,et al.  miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..

[43]  M. Robinson,et al.  Small-sample estimation of negative binomial dispersion, with applications to SAGE data. , 2007, Biostatistics.

[44]  Michael B. Stadler,et al.  Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome , 2007, Nature Genetics.

[45]  R. Cohn,et al.  Recognition of Li Fraumeni syndrome at diagnosis of a locally advanced extremity rhabdomyosarcoma , 2007, Pediatric blood & cancer.

[46]  M. Fraga,et al.  Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. , 2007, Cancer research.

[47]  Wenbin Ye,et al.  MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia , 2006, PloS one.

[48]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[49]  E. Olson,et al.  A Drosophila model of the rhabdomyosarcoma initiator PAX7-FKHR , 2006, Proceedings of the National Academy of Sciences.

[50]  A. Iolascon,et al.  Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation. , 2006, Carcinogenesis.

[51]  G. Hannon,et al.  Control of translation and mRNA degradation by miRNAs and siRNAs. , 2006, Genes & development.

[52]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[53]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[54]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[55]  M. Cleary,et al.  Binding to Nonmethylated CpG DNA Is Essential for Target Recognition, Transactivation, and Myeloid Transformation by an MLL Oncoprotein , 2004, Molecular and Cellular Biology.

[56]  P. M. Das,et al.  DNA methylation and cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  P. Ferri,et al.  C2C12 murine myoblasts as a model of skeletal muscle development: morpho-functional characterization. , 2004, European journal of histochemistry : EJH.

[58]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[59]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[60]  H. McDowell,et al.  Update on childhood rhabdomyosarcoma , 2003, Archives of disease in childhood.

[61]  G. Grosveld,et al.  Pax3-FKHR Knock-In Mice Show Developmental Aberrations but Do Not Develop Tumors , 2002, Molecular and Cellular Biology.

[62]  F. Barr,et al.  Molecular Pathogenesis of Rhabdomyosarcoma , 2002, Cancer biology & therapy.

[63]  R. Weksberg,et al.  Association of Alveolar Rhabdomyosarcoma with the Beckwith-Wiedemann Syndrome , 2001, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[64]  F. Barr.  Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma , 2001, Oncogene.

[65]  J. Issa,et al.  Changes in DNA Methylation in Neoplasia: Pathophysiology and Therapeutic Implications , 2001, Annals of Internal Medicine.

[66]  G. Merlino,et al.  Rhabdomyosarcoma – working out the pathways , 1999, Oncogene.

[67]  H. Werner,et al.  The Role of the Insulin‐like Growth Factor‐I Receptor in Cancer , 1995, Annals of the New York Academy of Sciences.

[68]  D. Harms.  New entities, concepts, and questions in childhood tumor pathology. , 1995, General & diagnostic pathology.

[69]  E. Gehan,et al.  The intergroup rhabdomyosarcoma study‐I. A final report , 1988, Cancer.

[70]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[71]  A. Schwartz,et al.  Association of childhood rhabdomyosarcoma with neurofibromatosis type i and birth defects , 1995, Genetic epidemiology.

[72]  P. Lollini,et al.  Reduced metastatic ability of in vitro differentiated human rhabdomyosarcoma cells. , 1991, Invasion & metastasis.